A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma. - Ding, Yangyang; Huang, Keke; Sun, Cheng; Liu, Zelin; Zhu, Jinli; Jiao, Xunyi; Liao, Ya; Feng, Xiangjiang; Guo, Jingjing; Zhu, Chunhua; Zhai, Zhimin; Xiong, Shudao (Scientific Reports, 2024)